Pancreatic β‐cell fate in subjects with COVID‐19

Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes investigation 2021-12, Vol.12 (12), p.2126-2128
1. Verfasser:	Shirakawa, Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Beta cells Cell fate Commentaries Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - metabolism Diabetes Diabetes mellitus Diabetes Mellitus - epidemiology Diabetes Mellitus - metabolism Diabetes Mellitus - virology Disease transmission eIF-2 kinase Enzymes Glucagon Heparan sulfate Humans Immunofluorescence Infections Initiation factor eIF-2 Insulin Insulin-Secreting Cells - metabolism Insulin-Secreting Cells - virology Kinases Pancreas Pathogenesis Phosphorylation Protein kinase R Proteins SARS-CoV-2 - metabolism Severe acute respiratory syndrome coronavirus 2 Signal transduction Trypsin Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes.
ISSN:	2040-1116 2040-1124
DOI:	10.1111/jdi.13671